Name | Recombinant Human ULBP-3 Fc Chimera Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 1517-UL |
Category | Protein |
Prices | $329.00 |
Sizes | 50 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Human ULBP-3 (Gly27 - Pro216 & His32 - Pro216) Accession # NP_078794 IEGRMD Human IgG 1 (Pro100 - Lys330) N-terminus C-terminus |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to bind with rhNKG2D/Fc Chimera in a functional ELISA. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | NP_078794 |
Gene | ULBP3 |
Sequence | Gly27 & His32 |
Supplier Page | Shop |
Giannattasio A, Weil S, Kloess S, Ansari N, Stelzer EH, Cerwenka A, Steinle A, Koehl U, Koch J. BMC Cancer. 2015 May 3;15:351.
Mou X, Zhou Y, Jiang P, Zhou T, Jiang Q, Xu C, Liu H, Zheng T, Yuan G, Zhang Y, Chen D, Mao C. Sci Rep. 2014 Aug 20;4:6138.
Nuckel H, Switala M, Sellmann L, Horn PA, Durig J, Duhrsen U, Kuppers R, Grosse-Wilde H, Rebmann V. Leukemia. 2010 Jun;24(6):1152-9.
Ho VT, Vanneman M, Kim H, Sasada T, Kang YJ, Pasek M, Cutler C, Koreth J, Alyea E, Sarantopoulos S, Antin JH, Ritz J, Canning C, Kutok J, Mihm MC, Dranoff G, Soiffer R. Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15825-30. doi: